We just can't afford it, another CR would be a drop in the ocean for what developing a drug would cost for example a phase III trial would include a few hundred patients at least and we aren't even up to that phase yet.
Our ADAPT products have already been developed and we can sell them right away. Where pumping extra money into something that might be a success years down the track is just a gamble.
Plus we could still hold some equity share and we won't have to worry where the funding will come from.
- Forums
- ASX - By Stock
- AVR
- Vax spin-off / partnership
Vax spin-off / partnership, page-3
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$12.56 |
Change
-0.740(5.56%) |
Mkt cap ! $265.4M |
Open | High | Low | Value | Volume |
$13.06 | $13.30 | $12.55 | $359.0K | 27.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 399 | $12.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.78 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 399 | 12.560 |
1 | 722 | 12.550 |
2 | 216 | 12.500 |
1 | 80 | 12.400 |
1 | 50 | 12.350 |
Price($) | Vol. | No. |
---|---|---|
12.780 | 500 | 1 |
12.800 | 712 | 2 |
13.000 | 1793 | 3 |
13.250 | 1000 | 1 |
13.300 | 3 | 1 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |